<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04031118</url>
  </required_header>
  <id_info>
    <org_study_id>Len-003</org_study_id>
    <nct_id>NCT04031118</nct_id>
  </id_info>
  <brief_title>Corneal Oxygen Uptake With Apioc Contact Lenses</brief_title>
  <official_title>Corneal Oxygen Uptake With Apioc Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lentechs, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lentechs, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine if a new investigational contact lens shape
      allows the eye to get more oxygen.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Oxygen Uptake Rate</measure>
    <time_frame>up to 45 seconds</time_frame>
    <description>uptake of oxygen by human cornea in vivo</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Contact Lens-Induced Corneal Disorder of Both Eyes (Diagnosis)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Apioc Contact Lens</intervention_name>
    <description>Measurement of corneal oxygen uptake with contact lens wear.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provide informed consent.

          2. Appear willing and able to adhere to instructions set forth in the protocol.

          3. Be between the ages of 18 and 45.

          4. Be an experienced contact lens wearer.

          5. Be an eyecare clinician or clinician-in-training.

          6. Flat and steep keratometry readings within 40 to 50D.

          7. Clear, healthy corneas with no irregular astigmatism.

          8. Normal, healthy conjunctiva in both eyes.

          9. Be able to provide corneal topography measurements.

         10. Be able to provide manifest refraction measurements.

        Exclusion Criteria:

          1. Irregular corneal astigmatism.

          2. Use of topical or systemic antihistamines within the previous week.

          3. Use of topical ophthalmic drops within the previous two days.

          4. History of corneal surgery.

          5. Currently pregnant or lactating.

          6. Systemic disease that would interfere with contact lens wear.

          7. Previous diagnosis of dry eye syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rev1 Ventures</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT04031118/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

